Drug Profile
PP 1010525
Alternative Names: Arnophyte; PP-1010525Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Piramal Life Sciences
- Developer Piramal Phytocare
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Herpes simplex virus infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Herpes-simplex-virus-infections in India (Topical)
- 10 Sep 2012 Pharmacodynamics data from a preclincial study in Herpes simplex virus infections presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2012)
- 15 Jun 2012 Preclinical trials in Herpes simplex virus infections in India (topical)